other_material
confidence high
sentiment neutral
materiality 0.75
TriSalus completes Preferred Stock exchange; 98.82% tendered at 3.3 common shares each
TriSalus Life Sciences, Inc.
- Approximately 98.82% of outstanding Series A Convertible Preferred Stock (3,551,502 shares) validly tendered in exchange offer.
- Each preferred share exchanged for 3.3 shares of common stock, based on a $4.00 per common share conversion price.
- Amendment to Certificate of Designations filed July 24, 2025, enabling mandatory conversion of remaining preferred shares.
- Settlement of all validly tendered shares expected on or before August 1, 2025.
item 3.03item 5.03item 5.07item 8.01item 9.01